Galderma announces its continued partnership with National Breast Cancer Foundation Inc. (NBCF), a leading breast cancer organization. Galderma is committed to elevating real people’s unique skin stories to increase the understanding of treatment needs for patients of all backgrounds and experiences, according to company officials. 

Galderma is featuring the personal stories and treatment journeys of breast cancer survivors who received Galderma’s aesthetic portfolio of products, including Restylane®Dysport®* (abobotulinumtoxinA) and/or Sculptra®, in a campaign on Galderma’s social channels during Breast Cancer Awareness Month in October.

“We are proud to work with National Breast Cancer Foundation on this important and exciting project that honors breast cancer survivors,” says Carrie Caulkins, vice president, U.S. Aesthetics Marketing at Galderma. “People who have finished their treatments of chemotherapy or radiation can experience loss of facial volume, which may lower their confidence following treatment. Our collaboration with NBCF enables us to support these patients and show how they can continue to look and feel their best using our leading portfolio of aesthetic products and treatments.”

This year, women from a variety of backgrounds, who have all lived with breast cancer, will be featured in video content throughout the month of October where they discuss their cancer journeys and how embracing injectables has given them the confidence to feel like themselves again.

In the month of October, Galderma will also be donating $50,000 to NBCF, bringing the total cash donation to $450,000 over the course of eight years. These funds will provide help and inspire hope to those affected by breast cancer through early detection, education, and support services.

Galderma and NBCF have had a longstanding partnership since 2015, providing ongoing financial support and contributions to a wide range of NBCF-offered programs. This includes educating and providing resources to more than 250,000 women, providing nearly 750 mammograms and diagnostic services across the U.S., supporting more than 6,500 women through patient navigation to provide help and support throughout their breast cancer journey, and contributing to the delivery of more than 20,000 HOPE Kits to breast cancer patients, which include a variety of educational materials and self-care items, including Cetaphil® lotion.

“We are extremely grateful for the contributions we have received from Galderma over the past seven years that have aided our ability to empower women to take action and receive critical support to get through the many challenges of a breast cancer diagnosis,” says Candice Hensley, NBCF’s senior manager of strategic partnerships. “We look forward to continuing our long-standing partnership and realizing our shared mission of elevating stories to raise awareness and inspire hope.”

To follow along with the breast cancer survivors’ skin stories, visit, and